BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs2476601
,
KLK3
,
Metabolism of xenobiotics
,
Breast Cancer
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphoribosyltransferase
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Congenital disorder
Macrophages cells treated with Nicotinate phosphoribosyltransferase or Lipopolysaccharides
Mouse Phenotypes - Deficiency of transferase
NAMPT, NMNAT-1, and SIRT1 knockdown in MCF-7 cells
Fibroblasts with a targeted knockdown of HPRT
Explore Curated Studies Results
Literature
Most Relevant Literature
Hypoxanthine-guanine phosphoribosyltransferase deficiency in a patient with a Madrid II mutation.
Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxo…
Mechanism of feedback allosteric inhibition of ATP phosphoribosyltransferase.
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytos…
Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Prospective Research Rare Kidney Stones (ProRKS)
Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion
Physiotherapy Assessment Based on the ICF Model in The Lesch-Nyhan Syndrome: Case Report
Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers
Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ